---
figid: PMC12245983__12032_2025_2879_Fig5_HTML
figtitle: PI3K/Akt/mTOR signalling pathway is activated upon binding of growth factor
  to receptor tyrosine kinase (RTK), which results in autophosphorylation of tyrosine
  residues and recruits phosphatidyl-inositol-3-kinase (PI3K) to cell membrane
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12245983
filename: 12032_2025_2879_Fig5_HTML.jpg
figlink: /pmc/articles/PMC12245983/figure/F5/
number: F5
caption: PI3K/Akt/mTOR signalling pathway is activated upon binding of growth factor
  to receptor tyrosine kinase (RTK), which results in autophosphorylation of tyrosine
  residues and recruits phosphatidyl-inositol-3-kinase (PI3K) to cell membrane. Activated
  PI3K phosphorylates phosphatidylinositol-3,4,5-biphosphate (PIP2) converting it
  to phosphatidylinositol-3,4,5-triphosphate (PIP3). PIP3 recruits AKT to cell surface
  for its activation by phosphorylation at two key residues. AKT phosphorylates tuberous
  sclerosis protein 2 (TSC2) releases inhibitory effect on mTORC1. mTORC1 would activate
  p70 S6K and inhibit 4E-BP1 while mTORC2 activates AKT. AKT also causes glucose transporter
  4 (GLUT4) to translocate to cell surface to facilitate glucose uptake. AKT inhibits
  glycogen synthase kinase 3 beta (GSK-3β) to increase glycogen production. Negative
  regulator phosphatases and tensin homolog (PTEN) converts PIP3 back to PIP2
papertitle: 'Exploring resveratrol’s inhibitory potential on lung cancer stem cells:
  a scoping review of mechanistic pathways across cancer models'
reftext: Alisa Raihana Saiful Hakim, et al. Med Oncol. 2025 Jul 10;42(8).
year: '2025'
doi: 10.1007/s12032-025-02879-y
journal_title: Medical Oncology (Northwood, London, England)
journal_nlm_ta: Med Oncol
publisher_name: .na.character
keywords: Lung cancer stem cells | Resveratrol | Wnt/β-catenin | Notch | PI3K/Akt/mTOR
  | Hedgehog
automl_pathway: 0.9130098
figid_alias: PMC12245983__F5
figtype: Figure
redirect_from: /figures/PMC12245983__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12245983__12032_2025_2879_Fig5_HTML.html
  '@type': Dataset
  description: PI3K/Akt/mTOR signalling pathway is activated upon binding of growth
    factor to receptor tyrosine kinase (RTK), which results in autophosphorylation
    of tyrosine residues and recruits phosphatidyl-inositol-3-kinase (PI3K) to cell
    membrane. Activated PI3K phosphorylates phosphatidylinositol-3,4,5-biphosphate
    (PIP2) converting it to phosphatidylinositol-3,4,5-triphosphate (PIP3). PIP3 recruits
    AKT to cell surface for its activation by phosphorylation at two key residues.
    AKT phosphorylates tuberous sclerosis protein 2 (TSC2) releases inhibitory effect
    on mTORC1. mTORC1 would activate p70 S6K and inhibit 4E-BP1 while mTORC2 activates
    AKT. AKT also causes glucose transporter 4 (GLUT4) to translocate to cell surface
    to facilitate glucose uptake. AKT inhibits glycogen synthase kinase 3 beta (GSK-3β)
    to increase glycogen production. Negative regulator phosphatases and tensin homolog
    (PTEN) converts PIP3 back to PIP2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - MTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - RPTOR
  - RPS6KB1
  - RPS6KB2
  - MDM2
  - TP53
  - TP63
  - TP73
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SLC2A4
  - EIF4EBP1
  - tyrosine
  - Raptor
---
